Abacus Planning Group Inc. Has $1.24 Million Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Abacus Planning Group Inc. lessened its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 3.4% in the 4th quarter, Holdings Channel reports. The firm owned 2,449 shares of the healthcare conglomerate’s stock after selling 86 shares during the quarter. Abacus Planning Group Inc.’s holdings in UnitedHealth Group were worth $1,239,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also modified their holdings of the company. Parthenon LLC raised its holdings in UnitedHealth Group by 12.3% in the 4th quarter. Parthenon LLC now owns 546 shares of the healthcare conglomerate’s stock worth $276,000 after acquiring an additional 60 shares during the period. Financial Perspectives Inc increased its holdings in shares of UnitedHealth Group by 7.2% during the 4th quarter. Financial Perspectives Inc now owns 4,459 shares of the healthcare conglomerate’s stock worth $2,256,000 after purchasing an additional 300 shares during the period. Alberta Investment Management Corp lifted its stake in UnitedHealth Group by 211.4% during the fourth quarter. Alberta Investment Management Corp now owns 24,915 shares of the healthcare conglomerate’s stock worth $12,604,000 after purchasing an additional 16,915 shares during the period. Summit Place Financial Advisors LLC lifted its stake in UnitedHealth Group by 5.1% during the fourth quarter. Summit Place Financial Advisors LLC now owns 5,162 shares of the healthcare conglomerate’s stock worth $2,611,000 after purchasing an additional 249 shares during the period. Finally, Vista Capital Partners Inc. raised its stake in shares of UnitedHealth Group by 19.3% in the fourth quarter. Vista Capital Partners Inc. now owns 737 shares of the healthcare conglomerate’s stock valued at $373,000 after acquiring an additional 119 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

UNH opened at $510.75 on Thursday. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $630.73. The firm has a market capitalization of $470.03 billion, a PE ratio of 32.95, a P/E/G ratio of 1.37 and a beta of 0.61. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The company has a fifty day moving average price of $520.62 and a two-hundred day moving average price of $561.67.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. During the same quarter in the previous year, the business earned $5.83 EPS. The firm’s revenue was up 6.8% on a year-over-year basis. As a group, analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

Insider Activity at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn purchased 1,000 shares of the business’s stock in a transaction on Friday, January 17th. The shares were purchased at an average cost of $511.57 per share, with a total value of $511,570.00. Following the transaction, the director now directly owns 4,500 shares of the company’s stock, valued at $2,302,065. This represents a 28.57 % increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 0.33% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

A number of research analysts have recently issued reports on UNH shares. Piper Sandler cut their target price on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a research note on Thursday, January 2nd. KeyCorp reiterated an “overweight” rating and issued a $650.00 target price on shares of UnitedHealth Group in a research note on Friday, January 17th. Stephens lifted their target price on shares of UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a research note on Thursday, December 5th. Oppenheimer lifted their target price on shares of UnitedHealth Group from $610.00 to $640.00 and gave the company an “outperform” rating in a research note on Friday, December 6th. Finally, StockNews.com raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Thursday, January 23rd. One analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Buy” and a consensus price target of $629.32.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.